Literature DB >> 10813486

Cerebrospinal fluid studies in children with cerebral malaria: an excitotoxic mechanism?

M Dobbie1, J Crawley, C Waruiru, K Marsh, R Surtees.   

Abstract

The pathogenesis of cerebral malaria is poorly understood. One hypothesis is that activation of microglia and astrocytes in the brain might cause the cerebral symptoms by excitotoxic mechanisms. Cerebrospinal fluid was sampled in 97 Kenyan children with cerebral malaria, 85% within 48 hr of admission. When compared with an age-matched reference range, there were large increases in concentrations of the excitotoxin quinolinic acid (geometric mean ratio cerebral malaria/reference population [95% confidence limits] = 14.1 [9.8-20.4], P < 0.001) and total neopterin (10.9 [9.1-13.0], P < 0.001) and lesser increases in tetra-hydrobiopterin, di-hydrobiopterin, and 5-hydroxyindoleacetic acid. There was no change in tryptophan concentration. In contrast, nitrate plus nitrite concentrations were decreased (geometric mean ratio = 0.45 [0.35-0.59], P < 0.001). There was a graded increment in quinolinic acid concentration across outcome groups of increasing severity. The increased concentration of quinolinic acid suggests that excitotoxic mechanisms may contribute to the pathogenesis of cerebral malaria.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10813486     DOI: 10.4269/ajtmh.2000.62.284

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  25 in total

Review 1.  Non-traumatic coma in children.

Authors:  F J Kirkham
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

Review 2.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

3.  Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition.

Authors:  Catherine J Clark; Gillian M Mackay; George A Smythe; Sonia Bustamante; Trevor W Stone; R Stephen Phillips
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Electroencephalographic and clinical features of cerebral malaria.

Authors:  J Crawley; S Smith; P Muthinji; K Marsh; F Kirkham
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

5.  Early Immune Regulatory Changes in a Primary Controlled Human Plasmodium vivax Infection: CD1c+ Myeloid Dendritic Cell Maturation Arrest, Induction of the Kynurenine Pathway, and Regulatory T Cell Activation.

Authors:  Tonia Woodberry; Jessica R Loughland; Gabriela Minigo; Julie G Burel; Fiona H Amante; Kim A Piera; Yvette McNeil; Tsin W Yeo; Michael F Good; Denise L Doolan; Christian R Engwerda; James S McCarthy; Nicholas M Anstey
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

6.  Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications.

Authors:  Bert K Lopansri; Nicholas M Anstey; Gregory J Stoddard; Esther D Mwaikambo; Craig S Boutlis; Emiliana Tjitra; Helena Maniboey; Maurine R Hobbs; Marc C Levesque; J Brice Weinberg; Donald L Granger
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 7.  Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome.

Authors:  Richard Idro; Kevin Marsh; Chandy C John; Charles R J Newton
Journal:  Pediatr Res       Date:  2010-10       Impact factor: 3.756

Review 8.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

9.  Benzo[b]quinolizinium Derivatives Have a Strong Antimalarial Activity and Inhibit Indoleamine Dioxygenase.

Authors:  Esther Jortzik; Kathleen Zocher; Antje Isernhagen; Boniface M Mailu; Stefan Rahlfs; Giampietro Viola; Sergio Wittlin; Nicholas H Hunt; Heiko Ihmels; Katja Becker
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

10.  Glucose metabolism mediates disease tolerance in cerebral malaria.

Authors:  Andrew Wang; Sarah C Huen; Harding H Luan; Kelly Baker; Henry Rinder; Carmen J Booth; Ruslan Medzhitov
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.